TY - JOUR
T1 - Self-monitoring of ambulatory blood pressure by the microlife WatchBP O3-An application test
AU - Nakano, Hajime
AU - Kikuya, Masahiro
AU - Hara, Azusa
AU - Nakashita, Manami
AU - Hirose, Takuo
AU - Obara, Taku
AU - Metoki, Hirohito
AU - Inoue, Ryusuke
AU - Asayama, Kei
AU - Ohkubo, Takayoshi
AU - Totsune, Kazuhito
AU - Imai, Yutaka
N1 - Funding Information:
This work was supported by a Grant-in-Aid from Microlife. This study was also supported in part by Grants for Scientific Research (15790293, 16590433, 17790381, 18390192, 18590587, 19590929, and 19790423) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid (H17-Kenkou-007, H18-Junkankitou [Seishuu]-Ippan-012, and H20-Junkankitou [Seishuu]-Ippan-009, 013) from the Ministry of Health, Labor and Welfare, Health and Labor Sciences Research Grants, Japan; Grants-in-Aid for Japan Society for the Promotion of Science (JSPS) fellows (16.54041, 18.54042, 19.7152, 20.7198, 20.7477, and 20.54043); Health Science Research Grants and Medical Technology Evaluation Research Grants from the Ministry of Health, Labor and Welfare, Japan; Japan Atherosclerosis Prevention Fund; Uehara Memorial Foundation; Takeda Medical Research Foundation; National Cardiovascular Research Grants; and Biomedical Innovation Grants.
PY - 2011/2
Y1 - 2011/2
N2 - Ambulatory blood pressure monitoring (ABPM) is not widely used in clinical practice, because the measuring procedure is complex and the devices are expensive and need to be fitted by skilled medical technologists. The Microlife WatchBP O3 (Microlife AG, Widnau, Switzerland), which was developed for self blood pressure monitoring at home and adapted for ABPM, is highly affordable for an ABPM device and easy to manipulate. We performed an application test of the WatchBP O3 to confirm reliability of the device. Thirty-seven volunteer participants (age 30.4 ± 13.5 y) underwent blood pressure (BP) measurements every 30 min for 24 h, and were asked to complete a questionnaire about the user-friendliness and acceptability of the device. The participants were asked to attach the device and to detach it the next morning by themselves. The quality of recordings was assessed in terms of percentage of valid readings. The mean number of 24-h BP readings per participant was 46.6 ± 5.3. The percentage of valid readings was 90%, which was similar to that reported for traditional ambulatory devices. Eighty-six percent of participants found it is "easy" or "very easy" to attach the device by themselves. The WatchBP O3, which is easy to manipulate, may be convenient and acceptable for users. The percentage of valid readings is similar to that reported previously. A new era of self-monitoring of ambulatory BP is anticipated in the near future.
AB - Ambulatory blood pressure monitoring (ABPM) is not widely used in clinical practice, because the measuring procedure is complex and the devices are expensive and need to be fitted by skilled medical technologists. The Microlife WatchBP O3 (Microlife AG, Widnau, Switzerland), which was developed for self blood pressure monitoring at home and adapted for ABPM, is highly affordable for an ABPM device and easy to manipulate. We performed an application test of the WatchBP O3 to confirm reliability of the device. Thirty-seven volunteer participants (age 30.4 ± 13.5 y) underwent blood pressure (BP) measurements every 30 min for 24 h, and were asked to complete a questionnaire about the user-friendliness and acceptability of the device. The participants were asked to attach the device and to detach it the next morning by themselves. The quality of recordings was assessed in terms of percentage of valid readings. The mean number of 24-h BP readings per participant was 46.6 ± 5.3. The percentage of valid readings was 90%, which was similar to that reported for traditional ambulatory devices. Eighty-six percent of participants found it is "easy" or "very easy" to attach the device by themselves. The WatchBP O3, which is easy to manipulate, may be convenient and acceptable for users. The percentage of valid readings is similar to that reported previously. A new era of self-monitoring of ambulatory BP is anticipated in the near future.
KW - Microlife WatchBP O3
KW - ambulatory blood pressure monitoring (ABPM)
KW - application test
KW - blood pressure measurement
KW - hypertension
UR - http://www.scopus.com/inward/record.url?scp=79251524246&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79251524246&partnerID=8YFLogxK
U2 - 10.3109/10641963.2010.503300
DO - 10.3109/10641963.2010.503300
M3 - Article
C2 - 21142811
AN - SCOPUS:79251524246
SN - 1064-1963
VL - 33
SP - 34
EP - 40
JO - Clinical and Experimental Hypertension
JF - Clinical and Experimental Hypertension
IS - 1
ER -